Interview with Warren Chen, Country Manager, Celgene Taiwan
Could you please give our readers an overview of the importance of Taiwan for Celgene in a regional and a global context? What is attractive in Taiwan for Celgene? Celgene…
The Development Fund of the Executive Yuan is in its 30th year since establishment in 1973. In its early years, the Fund invested in petrochemical and semiconductor industries that were vital to national development plans. In recent years, the focus of its investment has shifted to the biotechnology and digital content industries; in line with Taiwan’s economic transformation and strategic development directions.
The Fund’s investment scope currently embraces semiconductors, optoelectronics, communications, financial services, precision machinery, transportation infrastructure, and biotechnology. The primary goal of the Fund is to serve as a catalyst for Taiwan’s economic development and to accomplish a multiplier effect in the courses of its investment process.
Economic development is the aspiration of all people in Taiwan. It is our expectation that the Development Fund can serve as a driver for Taiwan’s economy. Not only would the Fund propel forward our industries on the international stage, it would enable us to accomplish new grounds of industrial and economic achievements.
Could you please give our readers an overview of the importance of Taiwan for Celgene in a regional and a global context? What is attractive in Taiwan for Celgene? Celgene…
Novo Nordisk is one of the few pharmaceutical multinationals focused in one key therapeutic area. Perhaps you could start by telling our readers about how diabetes has evolved in Taiwan…
Please tell our readers about the importance of GSK Taiwan within the context of the company’s global operations, and also what there is in Taiwan that makes it so attractive…
Medigen was created in 1999 and is a listed company. How did the vision for the company come about, and what was it that attracted today’s main shareholders to Medigen?…
Genovate was founded in 1995. It is a very interesting story: a mix of biotech, the history with American company Genelabs, government investments and also private investment through Chinachem. Can…
Please describe the activities of the IRPMA to our readers, and explain the membership advantages of your association. Today the IRPMA consists of 37 multinational research-based pharmaceutical manufacturers, as well…
The Development Centre for Biotechnology was founded in 1984 as a tool for connecting biotechnological academia to the Taiwanese industry and promoting the strengths of Taiwan’s biopharmaceutical sector to the…
Please explain the factors that led to the creation of the Taiwan Intellectual Property Office, and its main activities today. For the Taiwanese government, intellectual property (IP) rights are very…
See our Cookie Privacy Policy Here
